Clincosm LogoSign in Get a demo

Myelodysplastic Syndrome (MDS)

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic Syndrome (MDS) Trial in United States (AMV564 14-Day CIV)

Completed
  • Myelodysplastic Syndrome (MDS)
  • AMV564 14-Day CIV
  • Duarte, California
  • +4 more
Oct 11, 2021

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

Completed
  • Myelodysplastic Syndrome (MDS)
  • +6 more
  • Gainesville, Florida
  • +10 more
Nov 30, 2020

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Worldwide (birinapant, Azacitidine, Placebo)

Terminated
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Glendale, Arizona
  • +75 more
Oct 18, 2016

Myelodysplastic Syndrome (MDS), Myelofibrosis (MF) Trial in Australia, United States (KB004, Monoclonal Antibody)

Suspended
  • Myelodysplastic Syndrome (MDS)
  • Myelofibrosis (MF)
  • KB004, Monoclonal Antibody
  • Palo Alto, California
  • +8 more
Nov 13, 2015

Myelodysplastic Syndrome (MDS) Trial in United States (Ezatiostat Hydrochloride)

Completed
  • Myelodysplastic Syndrome (MDS)
  • Ezatiostat Hydrochloride
  • Tucson, Arizona
  • +35 more
Oct 10, 2011